Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer

By Choy Hak   Pyo Hongryull   Kim Jae-sung   MacRae Rob  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 963-974

Informa Healthcare

Access to resources Recommend Favorite

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

By Sánchez Rosa   Esteban Emilio   Palacio Isabel   Fernández Yolanda   Muñiz Isabel   Vieitez Jose M.   Fra Joaquin   Blay Pilar   Villanueva Noemí   Uña Esther   Mareque Beatriz   Estrada Enrique   Buesa Jose M.   Lacave Angel J.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 459-463

Springer Publishing Company

Access to resources Recommend Favorite

Pemetrexed in advanced non-small cell lung cancer

By Gridelli Cesare   Maione Paolo   Rossi Antonio   Bareschino Maria Anna   Schettino Clorinda   Sacco Paola Claudia   Zeppa Rosario  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review

By Coukell A.J.   Noble S.   Faulds D.  

PharmacoEconomics, Vol. 15, Iss. 4, 1999-04 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite

Crizotinib: In Locally Advanced or Metastatic Non-Small Cell Lung Cancer

By Curran Monique P.  

Drugs, Vol. 72, Iss. 1, 2012-01 ,pp. : 99-107

Adis International

Access to resources Recommend Favorite